GSK

GSK, Merck and Pfizer in Ab&B’s sights as Chinese vaccine biotech files for IPO
Fierce Biotech
Thu, 01/23/25 - 11:40 am
Ab&B Bio-Tech
GSK
Merck
Pfizer
China
vaccines
IPOs
EU approves endometrial, lung cancer drugs from GSK and J&J
Pharmaphorum
Tue, 01/21/25 - 11:10 am
Eurioe
GSK
JNJ
endometrial cancer
lung cancer
Jemperli
Rybrevant
Lazcluze
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thu, 01/16/25 - 11:02 am
JPMHC 2025
M&A
JNJ
Intra-Cellular Therapeutics
GSK
IDRx
JPM25, Day 3: GSK’s liver disease plans, the Biotech CEO Sisterhood, and more
Fierce Biotech
Wed, 01/15/25 - 11:08 am
JPMHC 2025
GSK
Biotech CEO Sisterhood
JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US
Fierce Pharma
Tue, 01/14/25 - 06:21 pm
JPMHC 2025
Pharma CEOs
Sanofi
Paul Hudson
GSK
Emma Walmsley
vaccines
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
Fierce Biotech
Mon, 01/13/25 - 11:18 am
GSK
JPMHC 2025
IDRx
GIST
cancer
precision medicine
GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk
Mint
Tue, 01/7/25 - 06:56 pm
GSK
Pfizer
vaccines
RSV
Guillain-Barré Syndrome
Arexvy
Abrysvo
GSK bags breakthrough status for bone cancer drug
Pharmaphorum
Tue, 01/7/25 - 10:32 am
GSK
bone cancer
GSK5764227
breakthrough status
antibody-drug conjugate
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
How pharma was instrumental in President Jimmy Carter’s global health efforts
Pharma Voice
Fri, 01/3/25 - 09:57 am
Jimmy Carter
Merck
GSK
JNJ
Amgen
GSK posts mixed survival data for Jemperli/Zejula combo in first-line ovarian cancer
BioSpace
Fri, 12/20/24 - 11:24 am
GSK
Jemperli
Zejula
clinical trials
ovarian cancer
GSK and Muna Therapeutics partner to develop new treatments for Alzheimer’s
Biopharma Reporter
Tue, 12/10/24 - 11:33 am
GSK
Muna Therapeutics
Alzheimer's disease
GSK pens $45M Relation-ship with AI biotech to identify fibrotic, osteoarthritis targets
Fierce Biotech
Tue, 12/10/24 - 10:44 am
GSK
Relation
artificial intelligence
osteoarthritis
fibrotic diseases
ASH: With survival win against J&J's Darzalex, GSK bolsters case for return of myeloma ADC Blenrep
Fierce Pharma
Mon, 12/9/24 - 09:10 pm
ASH 2024
GSK
Blenrep
JNJ
Darzalex
Multiple Myeloma
GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's
Fierce Biotech
Thu, 12/5/24 - 11:49 am
GSK
Muna Therapeutics
Alzheimer's disease
GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
Fierce Pharma
Thu, 12/5/24 - 11:39 am
GSK
China
Zhifei
Shingrix
GSK goes East again, snagging option on preclinical DualityBio ADC for $30M
Fierce Biotech
Wed, 12/4/24 - 10:58 am
GSK
China
DualityBio
antibody-drug conjugates
GSK taps Rgenta to develop new RNA-targeting treatments, offering up to $500M per target
Fierce Biotech
Wed, 12/4/24 - 10:42 am
GSK
Rgenta Therapeutics
RNA
GSK scratches itch for phase 3 win, hitting goal in liver disease trial to open up untapped market
Fierce Biotech
Tue, 11/19/24 - 11:18 am
GSK
linerixibat
liver disease
clinical trials
GSK hails survival data with revived myeloma drug Blenrep
Pharmaphorum
Thu, 11/14/24 - 10:03 am
GSK
Blenrep
Multiple Myeloma
clinical trials

Pages